Compare WWD & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WWD | RMD |
|---|---|---|
| Founded | 1870 | 1989 |
| Country | United States | United States |
| Employees | N/A | 10600 |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.7B | 28.4B |
| IPO Year | 1994 | N/A |
| Metric | WWD | RMD |
|---|---|---|
| Price | $416.93 | $209.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 10 |
| Target Price | ★ $369.25 | $292.56 |
| AVG Volume (30 Days) | 832.8K | ★ 1.4M |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | 0.35% | ★ 1.13% |
| EPS Growth | ★ 19.63 | N/A |
| EPS | ★ 4.36 | N/A |
| Revenue | ★ $3,567,064,000.00 | N/A |
| Revenue This Year | $17.52 | $10.60 |
| Revenue Next Year | $8.95 | $7.41 |
| P/E Ratio | $96.44 | ★ $25.61 |
| Revenue Growth | ★ 7.30 | N/A |
| 52 Week Low | $233.31 | $180.27 |
| 52 Week High | $450.92 | $293.81 |
| Indicator | WWD | RMD |
|---|---|---|
| Relative Strength Index (RSI) | 58.79 | 62.00 |
| Support Level | $341.31 | $198.63 |
| Resistance Level | $450.92 | $211.74 |
| Average True Range (ATR) | 14.27 | 4.85 |
| MACD | -0.55 | 2.23 |
| Stochastic Oscillator | 49.49 | 99.14 |
Woodward Inc is an independent designer, manufacturer, and service provider of control solutions for the aerospace and industrial markets. It designs, produces, and services reliable, efficient, low-emission, and high-performance energy control products for diverse applications in challenging environments. The company operates in two segments, Aerospace and Industrial. The Aerospace segment provides fuel pumps, actuators, air valves, specialty valves, fuel nozzles, and thrust reverser actuation systems for turbine engines and nacelles, and flight deck controls, actuators, servo controls, motors, and sensors for aircraft. The Industrial segment offers actuators, valves, pumps, fuel injection systems, solenoids, ignition systems, speed controls, electronics and software, and sensors.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.